Alcohol dependence (AD) and nicotine dependence (ND) co-occur frequently (AD+ND). We integrated SNP-based, gene-based, and protein-protein interaction network analyses to identify shared risk genes or gene subnetworks for AD+ND in African Americans (AAs, N = 2,094) and European Americans (EAs, N = 1,207). The DSM-IV criterion counts for AD and ND were modeled as two dependent variables in a multivariate linear mixed model, and analyzed separately for the two populations. The most significant SNP was rs6579845 in EAs (p < 1.29 × 10 −8 ) in GM2A, which encodes GM2 ganglioside activator, and is a cis-expression quantitative locus that affects GM2A expression in blood and brain tissues. However, this SNP was not replicated in our another small sample (N = 678). We identified a subnetwork of 24 genes that contributed to the AD+ND criterion counts. In the gene-set analysis for the subnetwork in an independent sample, the Study of Addiction: Genetics and Environment project (predominately EAs), these 24 genes as a set differed in AD+ND versus control subjects in EAs (p = .041). Functional enrichment analysis for this subnetwork revealed that the gene enrichment involved primarily nerve growth factor pathways, and cocaine and amphetamine addiction. In conclusion, we identified a genome-wide significant variant at GM2A and a gene subnetwork underlying the genetic trait of shared AD+ND. These results increase our understanding of the shared (pleiotropic) genetic risk that underlies AD+ND.
| INTRODUCTION
Alcohol and nicotine are often used together. Severe heavy smoking is correlated with risky drinking behaviors (John et al., 2003) . Alcohol and nicotine can each moderate the physiological and psychological effects of the other (Hurley, Taylor, & Tizabi, 2012) . Oliver et al. (2013) found that pharmacological interaction between nicotine and alcohol mutually affects craving in a complex manner. Alcohol and nicotine potentiate each other's rewarding and antagonistic effects, and nicotine tends to alter the sedative and rewarding effects of Ehringer, 2008; True et al., 1999) .
Previous genome-wide association studies (GWAS) of alcohol dependence (AD) and nicotine dependence (ND) individually identified numerous significant risk loci (Gelernter, Kranzler, Sherva, Almasy, Herman, et al., 2014 , Zuo et al., 2012 , Treutlein et al., 2009 , Frank et al., 2012 , Tobacco, 2010 , Jorgenson et al., 2017 . A pooling-based GWAS for AD co-occurring with ND (AD+ND) in an Australian population identified significant markers at MARK1, DDX6, and KIAA1409 (Lind et al., 2010) . Another analysis (Zuo et al., 2013 ) also implemented GWAS analysis in publicly-available data sets to obtain a significant region of IPO11-HIR1A, which might harbor a causal variant for AD+ND in EAs.
In this study, we sought to identify shared risk genes or gene subnetworks that contribute to shared risk for AD+ND. Our discovery GWAS analysis included individuals who met DSM-IV diagnostic criteria for both AD and ND, and alcohol-and nicotine-exposed individuals without AD or ND (total N = 2,094 AAs, 1,207 EAs). Another 1,937 subjects (1,381 EAs and 556 AAs) from the SAGE study (Bierut et al., 2010; Edenberg et al., 2006) were used to validate our network findings. The analyses we carried out included (a) a multivariate linear mixed model to examine simultaneously criterion counts of AD and ND for the SNP-based analysis; (b) a dense module search within the protein-protein interaction (PPI) network to identify gene subnetworks enriched for AD and ND criterion count associated genes; (c) gene set analysis to assess the association of the genes involved in the identified subnetwork as a whole with AD+ND using independent case-control samples from SAGE, and (d) pathway enrichment analysis to evaluate whether genes in the subnetwork share pathway features.
| METHODS AND MATERIALS
2.1 | Subjects and diagnostic description 2.1.1 | Yale-Penn GWAS discovery samples All subjects included in the discovery sample were recruited for studies of the genetics of cocaine dependence, opioid dependence, and (1) were that individuals had to meet DSM-IV diagnostic criteria for both AD and ND. The inclusion criteria for controls were that individuals had exposure to both alcohol and nicotine, but did not meet DSM-IV criteria for dependence on either of these substances. In
Stage 1 (discovery sample), we used the criterion counts as an ordinal variable in the linear mixed models with AD+ND and control samples.
A total of 2,094 AAs (1,303 cases and 791 controls) and 1,207 EAs (1,079 cases and 128 controls) met the inclusion criteria (Table 1) . Our prior studies (such as Gelernter et al., 2015) have indicated that continuous/ordinal traits have more powerful than case/control design because of greater information content and improved specificity of the dependence measure, thus considering those subjects who met criteria for dependence on both substances (American Psychiatric Association, 1994), was then defined on the basis of criterion count.
The distribution of criterion counts in the discovery samples is showed in Table 2 .
Subjects gave written informed consent as approved by the institutional review boards at each clinical site, and certificates of confidentiality were obtained from the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism.
| Yale-Penn GWAS EA replication sample
This sample included another 1,439 EA subjects, recruited from the same sites and using the same recruitment instruments as the discovery sample, Of the subjects who were exposed to alcohol or nicotine, 637 had dual diagnosis of AD+ND, and 41 had neither AD nor ND.
2.1.3 | Independent sample used to evaluate the association of genes Involved in the subnetwork for AD cooccurring ND
The network validation analyses included GWAS data from the SAGE collaboration obtained after application from dbGAP (http:// www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs0000 92.v1.p1); SAGE includes individuals from the Collaborative Study on the Genetics of Alcoholism (Edenberg, 2002) , the Family Study of Cocaine Dependence (Bierut, Strickland, Thompson, Afful, & Cottler, 2008) , and the Collaborative Genetic Study of Nicotine Dependence (Bierut et al., 2007) . As SAGE included subjects in nuclear families and the gene-set analysis using the software SNPset (Sequence) Kernel Association Test (SKAT; Wu et al., 2010) allows only unrelated individuals, we randomly selected one subject from each nuclear family and combined these with the rest of the sample of unrelated individuals. Thus, we included 797 and 403 unrelated AD+ND subjects and 584 and 153 controls for EA and AA respectively, after applying the same selection criteria as for the discovery sample (Table 1) .
| Genotyping and quality control
Our GWAS discovery sample was genotyped on the Illumina HumanOmni1-Quad v1.0 microarray, which included 988,306 autosomal SNPs. Genotyping was conducted at the Yale Center for Genome Analysis and at the center for inherited disease research (CIDR). Genotypes were called using the GenomeStudio software V2011.1 and genotyping module version 1.8.4 (Illumina). Samples and SNPs were excluded from analysis based on predetermined quality control criteria, as described elsewhere The procedure used to control for population stratification has been described previously . Briefly, to verify and correct misclassification of selfreported race, we compared GWAS data from all subjects included herein with genotypes from the HapMap 3 reference CEU (CEPH collection), YRI (Yoruba in Ibadan, Nigeria), and CHB (Han Chinese in Beijing, China) populations. Principal component analysis was performed in the GWAS sample using Eigensoft software (Price et al., 2006) and 145, 472 SNPs that were common to our GWAS data set and the HapMap panel (after pruning GWAS SNPs for linkage disequilibrium, r 2 > 80%) to characterize the underlying genetic architecture of the samples. The first principle component (PC) score distinguished AAs and EAs; these groups were then analyzed separately. We conducted PC analyses within the two groups taken separately, and the first three PCs were used in all subsequent analyses to correct for residual population stratification.
| Genotype imputation
Imputation for the discovery and replication sample was described previously . In summary, genotypes for 
| Statistical analysis methods

| Association tests for the Yale-Penn GWAS sample
We used genome-wide efficient mixed model association (GEMMA; Zhou & Stephens, 2012) , for the SNP-trait association tests, using age, sex, and the first three PCs as covariates (Gelernter et al., 2015) .
GEMMA implements multivariate linear mixed models (mvLMMs; Zhou & Stephens, 2014) , which are statistical regression models that relate explanatory variables to multiple correlated outcome variables and have been widely applied in genetics because they can account for relatedness among samples (Henderson, 1984) . The algorithm is based on linear algebra techniques previously used for univariate
LMMs (Lippert et al., 2011) and extends them to mvLMMs. In this study, we used the mvLMMs to test associations between SNPs and criterion counts for AD and ND simultaneously. We also used quantile-quantile plots based on p-values of genome-wide SNPs to evaluate further the possibility of population stratification or other systematic biases.
| Searching modules enriched for genes associated with AD+ND in the Yale-Penn GWAS sample
The module search included two steps. First, we converted the results of SNP-based association from the multivariate GWAS on AD+ND to gene-based association using VEGAS (Liu et al., 2010) to choose the smallest p-value among all SNPs mapped to each gene, that is, based on the best p-value for each gene. Second, we used an R package, dmGWAS (Jia, Zheng, Long, Zheng, & Zhao, 2010) , to identify candidate subnetworks using gene-based p-value for each gene as input data and a node-weighted network analysis in the knowledge-based human PPI network. We used a comprehensive human brain tissuespecific PPI network downloaded from Tissue Net Database (Barshir et al., 2013) for the dense module search, which yielded subnetworks enriched with low p-value genes. The dense module searches were implemented separately for AAs and EAs.
We also searched for significant modules enriched for both ADand ND-related genes by a dual-evaluation strategy, in which the modules identified in EAs were used as the discovery data set, and the modules identified in AAs as the evaluation data set (Jia et al., 2010) . Subsequently, significant modules were extracted and merged to construct a subnetwork for further association analysis.
| Validation of associations based on genes assigned to subnetworks using the SAGE sample
To confirm the association of the genes involved in the gene subnetworks identified for AD+ND, a permutation test was used to obtain empirical p-values. We extracted all SNPs from the SAGE data set that were mapped to genes in the final subnetwork. We bootstrapped the data by randomly shuffling phenotypes and genotypes while leaving the correlation of phenotype with genotype unchanged. This process was repeated 10,000 times and 10,000 results (Zn) were obtained.
The empirical p value for the association of the subnetwork with AD +ND was evaluated by determining the proportion of the Zn less than or equal to the observed ones in the Zn data sets.
| Pathway enrichment analysis
We submitted the genes in the subnetwork to ConsensusPathDB (Kamburov, Stelzl, Lehrach, & Herwig, 2013) , a database for annotation, for pathway enrichment analysis. A hypergeometric test implemented in ConsensusPathDB was used to compute the enrichment pvalue for pathways, followed by false discovery rate (FDR) correction for multiple testing. We also used BioGPS software (Wu et al., 2009;  http://biogps.org/#goto=welcome), which implements a virtually unstructured format for integrating disparate gene annotation resources to observe gene expression.
3 | RESULTS
| Genome-wide multivariate analysis in EAs and AAs analyzed separately
There were significant phenotypic correlations of criterion counts for AD and ND in EAs (r = .43; p < .001) and in AAs (r = .78; p < .001), as expected. In EAs, three SNPs mapped to GM2A (GM2 ganglioside activator) were significantly associated with AD+ND (Table 3) , and the strongest association among the three genome-wide significant (GWS)
SNPs was at rs6579845 (p < 1.29 × 10 A post hoc search found that the most significant SNP, rs6579845, is a cis-expression quantitative locus. The association between rs6579845 and GM2A expression is significant in the dorsolateral prefrontal cortex from human postmortem samples (p = 5.34 × 10 −9 , p FDR < .0001) (Colantuoni et al., 2011) , and also highly significant (p = 9.47 × 10 −20 , p FDR < .0001) in peripheral blood (Westra et al., 2013) . Rs6579845 thus affects GM2A expression in blood and brain tissues.
However, replication for the association of rs6579845 in the Yale-Penn EA replication sample was not significant (p = .42).
| Modules enriched for genes associated with AD+ND
A dense module search within the PPI network was carried out for the results of gene-based analysis in AAs and EAs separately. We observed 2,482 and 2,804 modules in EAs and AAs, respectively, and further analyses using a dual-evaluation strategy identified five modules that were significant in the enrichment for AD+ND-associated genes for both AA and EA populations. Supporting Information Table S1 shows the associated genes and statistics for each of the five modules. Out of the five modules, we removed the overlapping genes and combined all the genes to reconstruct a final subnetwork that included 24 nonredundant genes (Supporting Information Table S1 ). Figure 2 shows the characteristics of this gene subnetwork.
| Validation of association for genes in the subnetwork in the SAGE sample
In total, we extracted 782 SNPs from the SAGE data that mapped to the 24-gene subnetwork identified in the discovery sample. We evaluated the cumulative evidence for association with AD+ND for these 782 SNPs, and observed significant enrichment of common variants for genes in the subnetwork compared to controls (p = .041) in the EA part of the SAGE data set, but not in the AA part.
| Pathway enrichment analysis
This analysis revealed a number of pathways that remained significantly enriched (p < .05) after FDR correction. The enriched pathways are related to oxytocin signaling pathway, the nerve growth factor pathway, calcium signaling in the CD4+T cell receptor pathway, ErbB2/ErbB3 signaling events, cocaine addiction, and amphetamine addiction (Supporting Information Table S2 ). Two of the 24 genes (JUN and PRKACB) were each involved in two of these pathways, and we found that JUN and PRKACB are highly expressed in lung and in brain occipital lobe (Supporting Information Figure S3a ,b).
| DISCUSSION
We used a multivariate method to study the genetics of AD and ND when they co-occur, that is, are comorbid. This was based on genetic epidemiological evidence demonstrating a shared genetic basis for these traits, and on their frequent comorbidity in clinical contexts (Hopfer et al., 2001; Schlaepfer et al., 2008; True et al., 1999) . The results based on analysis of the correlated phenotypes may be due to pleiotropy, as well as shared environment and individually-relevant genetic factors (Korte et al., 2012) . We observed a GWS association signal in EAs at rs6579845 (p < 1.29 × 10 −8 ); this maps to the GM2A (GM2 ganglioside activator) gene. The protein encoded by this gene is a small glycolipid transport protein which acts as a substrate-specific co-factor for the lysosomal enzyme β-hexosaminidase A. Along with the GM2 ganglioside activator, it catalyzes the degradation of the ganglioside GM2, as well as other molecules containing terminal N-acetyl hexosamines. Deficiency of GM2 activator proteins can cause abnormal ganglioside storage in a mouse model (Liu et al., 1997) . On postnatal day 7 of brain exposure to ethanol, GM2 increased mainly in lysosomes/late endosomes of activated microglia, suggesting that GM2 may be derived from more complex gangliosides of degenerating neurons (Kolter & Sandhoff, 2006) . Increased GM2 by ethanol exposure is also found in mitochondria and lysosomes in neurons (Saito et al., 2012) . Abnormal lysosomes were related to chronic alcohol consumption and withdrawal, which specifically induces alterations in the medial prefrontal cortex, hippocampus, and cerebellum (Cadete-Leite, Alves, & Tavares, 1988) . These findings suggested that GM2 is associated with lysosomes in neurons, and regulates the nervous system, which might influence alcohol and nicotine dependence risk. However, this SNP rs6579845 was not replicated in another small sample (the Yale-Penn sample for replication has a low sample size which might make the replication result unreliable for this complex trait of AD and ND).
Based on genes identified by the gene-based and PPI analyses, we then identified a subnetwork of 24 AD+ND-associated genes (including GM2A). Pathway enrichment analysis also revealed that oxytocin signaling may have an important role in the pathological mechanism of AD+ND. We confirmed that the gene subnetwork association as a set differed between the AD+ND versus controls in the SAGE sample. The gene subnetwork was selected based on a PPI network that might include nonlinear interactions, so we tested the association of this gene subnetwork with AD+ND using the SNP-set SKAT, which applies a statistical framework that accounts for both linear and nonlinear interactions (Wu et al., 2010) . There was a significant association of the gene subnetwork with AD+ND (p = .041) in the SAGE EAs, but not AAs samples (This may be because the AA sample in SAGE is smaller than the EA sample, and provides lower power).
In the pathway enrichment analysis, the most significant pathway was oxytocin signaling. Oxytocin is mainly produced in the supraoptic, paraventricular, and accessory magnocellular nuclei of the hypothalamus (Sofroniew, 1983) . Oxytocin exerts diverse central and peripheral effects, though the most known and established roles are stimulating uterine contractions during childbirth and milk production during lactation (Augustine, Seymour, Campbell, Grattan, & Brown, 2018) . Oxytocin is also involved in cardiovascular regulation and various stress-related neuropsychiatric disorders (Iovino et al., 2018; Vargas-Martínez et al., 2017) .
Oxytocin peptide mRNA was significantly elevated in the prefrontal cortex of male subjects with alcohol use disorder compared to controls, using Chr = chromosome numbers; rs = snp ids; ps = base pair positions on the chromosome; beta_1 = beta estimates for the association of SNP with AD criterion counts); beta_2 = beta estimates for the association of SNP with ND criterion counts; p value was calculated for the association of SNP with criterion counts of AD and ND simultaneously.
FIGURE 1 Regional Manhattan plot of the genome-wide association analysis result for alcohol dependence co-occurring nicotine dependence in the European American sample. Significance of GWAS genotyped and imputed SNPs of the 400 kb region in the chromosomal region of GM2A post-mortem brain tissue . Other studies have also found that oxytocin was associated with nicotine dependence and withdrawal in rats (Lee, Jang, & Noh, 2017; Manbeck, Shelley, Schmidt, & Harris, 2014) , specifically that prenatal ethanol and nicotine exposure affects ethanol consumption, ethanol preference, and oxytocin receptor binding in adolescent and adult rats (Williams et al., 2009 ).
Our study highlights several advantages of combining SNP-based and network-based analysis of GWAS. First, we applied multivariate analytical tactics to integrate criterion counts for AD and ND phenotypes. Second, using network-based analysis, we identified 24 genes in the context of a PPI network. Third, pathway enrichment analyses of the genes in the subnetwork uncovered pathway annotations that may provide a better understanding the neurobiological mechanism of the pathway identified and thereby of AD+ND. Fourth, the significant association found in the subnetwork for AD+ND was replicated in the EA SAGE data set, demonstrating convergent validity for the findings.
Our study has several noteworthy limitations; foremost among these is the limitation in sample size. In addition, in our gene-based analysis implementation, we mapped gene-level p values by considering the smallest p value SNP in each gene. Under this model, association signals for genes with multiple independent risk variants are not well captured.
In conclusion, through integrated SNP-based, gene-based analyses, and PPI network analysis, we identified GM2A as a risk locus of genomewide significance, and more importantly, a specific gene subnetwork as relevant to the risk for AD+ND, which improves our understanding of one of (presumably many) shared biological mechanisms for these two traits. Dr. Kranzler declares to have been a consultant, advisory board member, or CME speaker for Indivior and Lundbeck. He is also a member of the American Society of Clinical Psychopharmacology's FIGURE 2 Gene subnetwork constructed with five significant modules generated in AAs and EAs in the AD co-occurring with ND GWAS data sets. All of the genes involved in each of the five significant modules were pulled together and resulted in 24 genes after the overlapping genes were removed (Supporting Information Table S1 ). Gene subnetwork of these 24 genes was generated from the human protein-protein interaction network; we used Cytoscape software (http://cytoscape.org/) to show the relationship between these genes Alcohol Clinical Trials Initiative (ACTIVE), which in the last 3 years
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